Search Results | Cancer Research | American Association for Cancer Research

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity

Anil Shanker, Samuel T. Pellom, Jr, Duafalia F. Dudimah, Menaka C. Thounaojam, Rachel L. de Kluyver, Alan D. Brooks, Hideo Yagita, Daniel W. McVicar, William J. Murphy, Dan L. Longo, Thomas J. Sayers

Cancer Res (2015) 75 (24): 5260–5272.

DOI: https://doi.org/10.1158/0008-5472.CAN-15-0794

Published: 14 December 2015

View article

Includes: Supplementary data

Journal Articles

Redox Modulation of Adjacent Thiols in VLA-4 by AS101 Converts Myeloid Leukemia Cells from a Drug-Resistant to Drug-Sensitive State

Adi Layani-Bazar, Itai Skornick, Alain Berrebi, Maor H. Pauker, Elad Noy, Alon Silberman, Michael Albeck, Dan L. Longo, Yona Kalechman, Benjamin Sredni

Cancer Res (2014) 74 (11): 3092–3103.

DOI: https://doi.org/10.1158/0008-5472.CAN-13-2159

Published: 29 May 2014

View article

Includes: Supplementary data

Journal Articles

Transcriptional Autoregulation by BRCA1

Adriana De Siervi, Paola De Luca, Jung S. Byun, Li Jun Di, Temesgen Fufa, Cynthia M. Haggerty, Elba Vazquez, Cristian Moiola, Dan L. Longo, Kevin Gardner

Cancer Res (2010) 70 (2): 532–542.

DOI: https://doi.org/10.1158/0008-5472.CAN-09-1477

Published: 13 January 2010

View article

Includes: Supplementary data

Journal Articles

Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation

Cancer Res (2008) 68 (24): 10205–10214.

DOI: https://doi.org/10.1158/0008-5472.CAN-08-2149

Published: 15 December 2008

View article

Includes: Supplementary data

Journal Articles

Traf1 Induction and Protection from Tumor Necrosis Factor by Nuclear Factor-κB p65 Is Independent of Serine 536 Phosphorylation

Carl Y. Sasaki, Colin F. Slemenda, Paritosh Ghosh, Theresa J. Barberi, Dan L. Longo

Cancer Res (2007) 67 (23): 11218–11225.

DOI: https://doi.org/10.1158/0008-5472.CAN-07-0922

Published: 03 December 2007

View article

Includes: Supplementary data

Journal Articles

Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression

Thomas J. O’Farrell, Paritosh Ghosh, Nobuaki Dobashi, Carl Y. Sasaki, Dan L. Longo

Cancer Res (2004) 64 (22): 8199–8207.

DOI: https://doi.org/10.1158/0008-5472.CAN-03-3639

Published: 17 November 2004

View article

Includes: Supplementary data

Journal Articles

Treatment of either cyclophosphamide or 5-fluorouracil improved rather than impaired spatial learning and neuronal function in young female rats

Garrick D. H. Lee, Yu Wang, Joseph M. Rifkind, Jacek Mamczarz, Edward Spangler, Mark P. Mattson, Dan L. Longo, Donald K. Ingram

Cancer Res (2004) 64 (7_Supplement): 1225–1226.

Published: 01 April 2004

View article

Journal Articles

Ammonium Trichloro(dioxoethylene- o,o ′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop

Benjamin Sredni, Merav Weil, Gennadi Khomenok, Ilana Lebenthal, Seagal Teitz, Yael Mardor, Zvi Ram, Arie Orenstein, Amir Kershenovich, Shalom Michowiz, Yan I. Cohen, Zvi H. Rappaport, Ilya Freidkin, Michael Albeck, Dan L. Longo, Yona Kalechman

Cancer Res (2004) 64 (5): 1843–1852.

DOI: https://doi.org/10.1158/0008-5472.CAN-03-3179

Published: 02 March 2004

View article

Journal Articles

Truncation of the Extracellular Region Abrogrates Cell Contact but Retains the Growth-suppressive Activity of E-cadherin

Carl Y. Sasaki, Hsingchi Lin, Patrice J. Morin, Dan L. Longo

Cancer Res (2000) 60 (24): 7057–7065.

Published: 01 December 2000

View article

Journal Articles

In Vivo Antitumor Effects of Unconjugated CD30 Monoclonal Antibodies on Human Anaplastic Large-Cell Lymphoma Xenografts

Zhi-Gang Tian, Dan L. Longo, Satoshi Funakoshi, Osamu Asai, Douglas K. Ferris, Michael Widmer, William J. Murphy

Cancer Res (1995) 55 (22): 5335–5341.

Published: 01 November 1995

View article

Journal Articles

Partial Degradation of T-Cell Signal Transduction Molecules by Contaminating Granulocytes during Protein Extraction of Splenic T Cells from Tumor-bearing Mice

José L. Franco, Paritosh Ghosh, Robert H. Wiltrout, Clive R. D. Carter, Arnold H. Zea, Nobuaki Momozaki, Augusto C. Ochoa, Dan L. Longo, Thomas J. Sayers, Kristin L. Komschlies

Cancer Res (1995) 55 (17): 3840–3846.

Published: 01 September 1995

View article

Journal Articles

Alterations in NFκB/Rel Family Proteins in Splenic T-Cells from Tumor-bearing Mice and Reversal following Therapy

Paritosh Ghosh, Antonio Sica, Howard A. Young, Jianping Ye, José L. Franco, Robert H. Wiltrout, Dan L. Longo, Nancy R. Rice, Kristin L. Komschlies

Cancer Res (1994) 54 (11): 2969–2972.

Published: 01 June 1994

View article

Journal Articles

Loss of T-Cell Receptor ζ Chain and p56^lck in T-Cells Infiltrating Human Renal Cell Carcinoma

James H. Finke, Arnold H. Zea, Jill Stanley, Dan L. Longo, Hiromoto Mizoguchi, Raymond R. Tubbs, Robert H. Wiltrout, John J. O'Shea, Seiji Kudoh, Eric Klein, Ronald M. Bukowski, Augusto C. Ochoa

Cancer Res (1993) 53 (23): 5613–5616.

Published: 01 December 1993

View article

Journal Articles

Interstitial Pressure of Subcutaneous Nodules in Melanoma and Lymphoma Patients: Changes during Treatment

Brendan D. Curti, Walter J. Urba, W. Gregory Alvord, John E. Janik, John W. Smith, II, Karen Madara, Dan L. Longo

Cancer Res (1993) 53 (10): 2204–2207.

Published: 01 May 1993

View article

Journal Articles

Prevention of Acute Chemotherapy-induced Death in Mice by Recombinant Human Interleukin 1: Protection from Hematological and Nonhematological Toxicities

Giovanna Damia, Kristin L. Komschlies, Hitoyasu Futami, Timothy Back, M. Eilene Gruys, Dan L. Longo, Jonathan R. Keller, Francis W. Ruscetti, Robert H. Wiltrout

Cancer Res (1992) 52 (15): 4082–4089.

Published: 01 August 1992

View article

Journal Articles

Polyinosinic-Polycytidylic Acid Complexed with Poly-l-lysine and Carboxymethylcellulose in Combination with Interleukin 2 in Patients with Cancer: Clinical and Immunological Effects¹

Cynthia H. Ewel, Walter J. Urba, William C. Kopp, John W. Smith, II, Ronald G. Steis, Jeffrey L. Rossio, Dan L. Longo, Mary Jane Jones, W. Gregory Alvord, Carl M. Pinsky, Joy M. Beveridge, Karen L. McNitt, Stephen P. Creekmore

Cancer Res (1992) 52 (11): 3005–3010.

Published: 01 June 1992

View article

Journal Articles

Anti-CD3 Monoclonal Antibody Treatment of Patients with CD3-Negative Tumors: A Phase IA/B Study

Walter J. Urba, Cynthia Ewel, William Kopp, John W. Smith, II, Ronald G. Steis, Jonathan D. Ashwell, Stephen P. Creekmore, Jeffrey Rossio, Mario Sznol, William Sharfman, Robert Fenton, John Janik, Thelma Watson, Joy Beveridge, Dan L. Longo

Cancer Res (1992) 52 (9): 2394–2401.

Published: 01 May 1992

View article

Journal Articles

Preclinical Evaluation of Bryostatin as an Anticancer Agent against Several Murine Tumor Cell Lines: In Vitro versus in Vivo Activity

Ronald L. Hornung, John W. Pearson, Margaret Beckwith, Dan L. Longo

Cancer Res (1992) 52 (1): 101–107.

Published: 01 January 1992

View article

Journal Articles

Antitumor Effects of Interleukin 2 Liposomes and Anti-CD3-Stimulated T-Cells against Murine MCA-38 Hepatic Metastasis

Cynthia M. Loeffler, Jeffrey L. Platt, Peter M. Anderson, Emmanuel Katsanis, Juan B. Ochoa, Walter J. Urba, Dan L. Longo, Arnold S. Leonard, Augusto C. Ochoa

Cancer Res (1991) 51 (8): 2127–2132.

Published: 01 April 1991

View article

Journal Articles

Interleukin 2 and Lymphokine-activated Killer Cell Therapy: Analysis of a Bolus Interleukin 2 and a Continuous Infusion Interleukin 2 Regimen

Jeffrey W. Clark, John W. Smith, II, Ronald G. Steis, Walter J. Urba, Edward Crum, Robin Miller, John McKnight, JoAnn Beman, Henry C. Stevenson, Stephen Creekmore, Michael Stewart, Kevin Conlon, Mario Sznol, Peter Kremers, Paul Cohen, Dan L. Longo

Cancer Res (1990) 50 (22): 7343–7350.

Published: 01 November 1990

View article

NARROW

Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity

Redox Modulation of Adjacent Thiols in VLA-4 by AS101 Converts Myeloid Leukemia Cells from a Drug-Resistant to Drug-Sensitive State

Transcriptional Autoregulation by BRCA1

Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation

Traf1 Induction and Protection from Tumor Necrosis Factor by Nuclear Factor-κB p65 Is Independent of Serine 536 Phosphorylation

Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression

Treatment of either cyclophosphamide or 5-fluorouracil improved rather than impaired spatial learning and neuronal function in young female rats

Ammonium Trichloro(dioxoethylene- o,o ′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop

Truncation of the Extracellular Region Abrogrates Cell Contact but Retains the Growth-suppressive Activity of E-cadherin

In Vivo Antitumor Effects of Unconjugated CD30 Monoclonal Antibodies on Human Anaplastic Large-Cell Lymphoma Xenografts

Partial Degradation of T-Cell Signal Transduction Molecules by Contaminating Granulocytes during Protein Extraction of Splenic T Cells from Tumor-bearing Mice

Alterations in NFκB/Rel Family Proteins in Splenic T-Cells from Tumor-bearing Mice and Reversal following Therapy

Loss of T-Cell Receptor ζ Chain and p56^lck in T-Cells Infiltrating Human Renal Cell Carcinoma

Interstitial Pressure of Subcutaneous Nodules in Melanoma and Lymphoma Patients: Changes during Treatment

Prevention of Acute Chemotherapy-induced Death in Mice by Recombinant Human Interleukin 1: Protection from Hematological and Nonhematological Toxicities

Polyinosinic-Polycytidylic Acid Complexed with Poly-l-lysine and Carboxymethylcellulose in Combination with Interleukin 2 in Patients with Cancer: Clinical and Immunological Effects¹

Anti-CD3 Monoclonal Antibody Treatment of Patients with CD3-Negative Tumors: A Phase IA/B Study

Preclinical Evaluation of Bryostatin as an Anticancer Agent against Several Murine Tumor Cell Lines: In Vitro versus in Vivo Activity

Antitumor Effects of Interleukin 2 Liposomes and Anti-CD3-Stimulated T-Cells against Murine MCA-38 Hepatic Metastasis

Interleukin 2 and Lymphokine-activated Killer Cell Therapy: Analysis of a Bolus Interleukin 2 and a Continuous Infusion Interleukin 2 Regimen

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only